It's in the nature of big pharma business for companies to play their cards close to their chest. They have to be careful not to give critical info to their competitors.
- Forums
- ASX - By Stock
- CSL - $300 and beyond
It's in the nature of big pharma business for companies to play...
-
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$307.53 |
Change
-0.400(0.13%) |
Mkt cap ! $148.6B |
Open | High | Low | Value | Volume |
$309.31 | $309.89 | $307.31 | $87.02M | 297.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 44 | $307.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$307.54 | 16 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11 | 307.640 |
3 | 20 | 307.630 |
1 | 10 | 307.610 |
2 | 11 | 307.600 |
1 | 3 | 307.590 |
Price($) | Vol. | No. |
---|---|---|
307.670 | 7 | 1 |
307.700 | 20 | 3 |
307.710 | 100 | 5 |
307.720 | 5 | 1 |
307.730 | 5 | 1 |
Last trade - 14.06pm 30/08/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online